Suppressed pro-inflammatory properties of circulating B cells in patients with multiple sclerosis treated with fingolimod, based on altered proportions of B-cell subpopulations

Suppressed pro-inflammatory properties of circulating B cells in patients with multiple sclerosis treated with fingolimod, based on altered proportions of B-cell subpopulations

Copyright © 2014 Elsevier Inc. All rights reserved.

Bibliographische Detailangaben
Veröffentlicht in:Clinical immunology (Orlando, Fla.). - 1999. - 151(2014), 2 vom: 28. Apr., Seite 127-35
1. Verfasser: Miyazaki, Yusei (VerfasserIn)
Weitere Verfasser: Niino, Masaaki, Fukazawa, Toshiyuki, Takahashi, Eri, Nonaka, Takayuki, Amino, Itaru, Tashiro, Jun, Minami, Naoya, Fujiki, Naoto, Doi, Shizuki, Kikuchi, Seiji
Format: Online-Aufsatz
Sprache:English
Veröffentlicht: 2014
Zugriff auf das übergeordnete Werk:Clinical immunology (Orlando, Fla.)
Schlagworte:Journal Article Research Support, Non-U.S. Gov't B cells CD80 Cytokine Fingolimod Multiple sclerosis Transitional B cells B7-1 Antigen CCR7 protein, human mehr... Immunosuppressive Agents Propylene Glycols Receptors, CCR7 Tumor Necrosis Factor-alpha Interleukin-10 130068-27-8 Fingolimod Hydrochloride G926EC510T Sphingosine NGZ37HRE42
Online verfügbar Volltext